SecFilingDex

Hemab Therapeutics Holdings, Inc.

27 SEC EDGAR filings indexed (CIK 0002114044) across 7 form types.

Filing profile

Hemab Therapeutics Holdings, Inc. (COAG) has 27 SEC filings indexed on SecFilingDex, across 7 form types, from April 10, 2026 to August 11, 2026. The filer is classified under Biological Products (SIC 2836).

Its most frequent disclosure is the Form 4 (Insider transaction) with 8 filings — Statement of changes in beneficial ownership filed by company officers, directors, and 10%+ owners. 27 of these filings were disclosed in the twelve months to August 11, 2026. 3 of the 27 are amendments (a corrected or updated version of an earlier filing).

Disclosure mix

  • 8Form 4Insider transaction · within 2 business days of transaction
  • 8Form 3Initial insider ownership · within 10 days of becoming an insider
  • 48-KMaterial event · event-driven
  • 3S-1/AIPO registration · event-driven (pre-ipo)
  • 210-QQuarterly report · quarterly
  • 1424B4Final prospectus · event-driven
  • 1S-1IPO registration · event-driven (pre-ipo)

Profile derived from 27 indexed filings; every figure traces to the filing records above, each linking back to its original SEC EDGAR document. Filing counts reflect SecFilingDex's current index, not the filer's complete EDGAR history.

All filings

Authoritative source

https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2114044&type=&dateb=&owner=include&count=40

SecFilingDex republishes EDGAR data with provenance. EDGAR is authoritative; this page reflects the most recent index pull.

Disclaimer: SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page is investment, legal, or tax advice.